Join an expert melanoma oncologist and interventional radiologist for an on-demand activity that delivers real-world insights from a national quality improvement initiative on advanced melanoma care. Faculty will explore practice gaps, emerging evidence, and strategies to optimize multidisciplinary management of patients who progress after anti-PD-1 therapy. This evidence-based program will: Uncover root causes of clinical practice gaps in treating advanced melanoma after anti-PD-1 progression Review clinical trial efficacy and safety data to inform personalized treatment planning Highlight approaches to identify patients who may be appropriate candidates for intratumoral immunotherapy Share practical strategies to strengthen referral pathways and communication between community oncology clinics, academic centers, and interventional radiologists Provide frameworks for designing clinical workflows that enhance collaboration, safety, and adverse event management in intratumoral immunotherapy.Participants will also gain access to downloadable, evidence-based slides and a Point-of-Care Guide to support ongoing application of the program’s key takeaways.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 17, 2025
-
Last day to claim creditOct 17, 2026 7 days left
-
PRIME Education, Inc. (PRIME®) Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma
-
PRIME Education, Inc. (PRIME®) Mastering Emerging Therapies in Advanced Urothelial Cancer: Practical Strategies for Combination Therapies, Adverse Event Management, and Team-Based Care
-
PRIME Education, Inc. (PRIME®) Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma
